glp-1 market growth Obesity Pharma Giants Bet on Next-Generation

Health Canada's January 21 advisory tells buyers to verify GLP-1 drugs via eight-digit DIN and Drug Product Database, and flags CBSA cooperation on shipments.

Researchers are flagging a potential safety concern tied to GLP-1 medications and blood pressure.A new Northwestern Medicine study tracked more than 42,000 adul

Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are approved for treating type 2 diabetes and weight loss

In this review, we summarize the state-of-the-art evidence regarding the epidemiology and pathophysiology of diabetic HFpEF, and the landscape of the novel antidiabetic drugs in the treatment of diabetic HFpEF, as well as discuss the relevant mechanisms, aiming to broaden the understanding of diabetic HFpEF and gain new insight into the treatment of this disease

Integrates with your website in minutes.